Bausch + Lomb Spotlights BL 1107 Eye Drop and ELIOS Implant-Free Laser as Glaucoma Catalysts [Yahoo! Finance]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Yahoo! Finance
Bausch + Lomb (NYSE:BLCO) highlighted two glaucoma programs during a Wells Fargo-hosted “2026 MedTech Innovation Spotlight” call, focusing on BL 1107, a next-generation alpha-2 agonist eyedrop, and ELIOS, an implant-free excimer laser procedure designed to lower intraocular pressure (IOP) during cataract surgery. Management framed glaucoma as neurodegenerative disease with unmet need Executive Vice President of R&D and Chief Medical Officer Dr. Yehia Hashad described glaucoma as a chronic neurodegenerative condition in which elevated IOP is a key risk factor, but not the sole driver. He said some patients can experience neurodegeneration despite “normal” IOP, contributing to a shift in how the disease is defined and managed. ? Macy's Beats Expectations Again, But Guidance Spooks Investors It's Time To Nibble On These Two Recent IPOs Hashad emphasized that glaucoma often progresses slowly and can go undetected until meaningful damage has occurred, noting patients may not rec
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling ProgramBusiness Wire
- Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced UpdateBusiness Wire
- Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in EuropeBusiness Wire
- Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual MeetingBusiness Wire
BLCO
Earnings
- 2/18/26 - Miss
BLCO
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- BLCO's page on the SEC website